Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

AstraZeneca UK vaccine partner says suspicious package made safe, production schedule unaffected

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid

A suspicious package at an AstraZeneca COVID-19 vaccine plant has been made safe and production schedules of the shots have not been affected, the company Wockhardt UK said on Wednesday.

"We can confirm that the investigation on the suspicious package received today has been concluded. Given that staff safety is our main priority manufacturing was temporarily paused whilst this took place safely. We can now confirm that the package was made safe and staff are now being allowed back into the facility," Wockhardt UK said in a statement.

"This temporary suspension of manufacturing has in no way affected our production schedule and we are grateful to the authorities and experts for their swift response and resolution of the incident."

(Reporting by Alistair Smout and Michael Holden; editing by James Davey)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.